Biotechnology Flashcards

1
Q

What are the two culture methods?

A

Batch and continuous.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do either of the methods differ?

A

Batch is a closed culture method where the products are removed at the end of the culture. Continuous culture has a constant inflow and outflow of substances. The bacteria is maintained in a homogenous grwoth condition.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the problem with producing eukaryotic proteins in prokaryotes?

A

There are major differences between prokaryotes and eukaryotes such as the regulatory sequences, introns, post-transcriptional processing/post-translational processing - so it is not as simple as it may seem!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a promoter?

A

Where transcription of a gene starts - RNA polymerase II binds.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is a terminator?

A

Where transcription stops.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is a ribosome binding site?

A

Where ribosomes attach to mRNA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do promoters/terminators and ribosome binding sites differ between eukaryotes and prokaryotes?

A

They are all different, meaning eukaryotic genes cannot work in a prokaryotic background.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How can the differences between prokaryotic and eukaryotic genes be solved?

A

Use a prokaryotic promoter and signals to drive the eukaryotic gene, such as special expression vectors that are already in the vector.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does using cDNA instead of the genomic clone mean?

A

It eliminates the problems from introns in eularyotic genes, but E.coli does not always process proteins as eukaryotic cells do.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What do E.coli expression vectors contain?

A

E.coli control sequences such as promoters, ribosome binding sites, restriction sites and terminators. The restriction site is located between the promoter and terminator.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do strong promoters and weak promoters differ?

A

Strong promoters sustain a high rate of transcription and are used for products that are needed in large amounts, whereas weak promoters are relatively inefficient and useful if your product is toxic at higher levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How can more sophisticated promoters work?

A

They can switch the gene on and off as convenient as some foreign proteins that need to be replicated may be harmful to the E.coli. This means large amounts can still be produced even if the E.coli cells die.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is an example of a more sophisticated regulatable promoter?

A

The lacZ promoter that can be activated with IPTG (an artificial inducer) to switch on the lacZ gene.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How can the Trp promoter be used?

A

The TrpA gene is involved in the biosynthesis of trptophan. If 3-beta-indoleacrylic acid is added it will be switched on and transcription will occur. Adding tryptophan will repress it as there is a negative feedback loop to prevent overproduction of tryptophan.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does the lambdaP1 promoter work?

A

It is temperature sensitive. Temperatures below 30 degrees allow no transcription.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is alternative method to solve the problem of the differences between prokaryotic and eukaryotic cells?

A

Express the eukaryotic genes in eukaryotes instead.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the benefits of using yeast to express eukaryotic proteins?

A

It is a well characterised system, it has a range of useful promoters, any differences in regulatory sequences from mammals is not a problem.

18
Q

What are the problems of using yeast to express eukaryotic genes?

A

Hyperglycosylation - some amino acids such as asparagine in humans is glycosylated, but in yeast there will be an excess of glycosylation. The secretion of proteins from yeast is also not efficient.

19
Q

What is another method, aside from yeast, to express eukaryotic proteins?

A

Expressing the proteins in animal cells.

20
Q

What is the method of expressing eukaryotic proteins on animal cells?

A

Cell culture - growing them on surfaces such as internal plates or inert particles such as cellulose beads.There is much slower growth than with microorganisms.

21
Q

How can they be grown on mammalian cells?

A

Using expression vectors with strong promoters, such as from SV40.

22
Q

How can they be grown on insect cells?

A

Expression system based on baculoviruses - the protein accumulates in inclusion bodies to high levels.

23
Q

What is another way to express eukaryotic proteins?

A

Expressing them in whole organisms (transgenics).

24
Q

How can transgenic animals be achieved?

A

Gene injection into the somatic nucleus. The nucleus is transferred to an oocyte with no nucleus and is then implanted into a foster mother to form an ovum. This is not a simple procedure.

25
Q

How can the product from a transgenic animal be gained?

A

Blood, eggs (of chickens), milk (cows).

26
Q

How can proteins only be expressed in the mammary gland of animals in transgenics?

A

The recombinant gene can be driven from the beta-lactoglobulin promoter. This creates a high yield.

27
Q

How can pharming be used in plants?

A

Plant cells can be grown in liquid culture and transformed with the Ti plasmid. Plants can be grown in a field and use a strong organ-specific promoter such as the seed of bean or potato tuber.

28
Q

What pharmaceuticals can be produced by plant pharming?

A

Interleukins, antibodies and vaccines.

29
Q

What are the ethics associated with pharming?

A

The suffering in animals such as Dolly the sheep, concerns about the environmental impact of plants and human health concerns due to the preconceived ideas about GM.

30
Q

How can recombinant pharmaceuticals be useful?

A

Many human disorders are due to the imbalance of proteins. This can be corrected by administering human protein, such as insulin to control glucose levels.

31
Q

How can recombinant insulin be produced?

A

The two artificial A and B genes can be cloned into separate inducible vectors. Fusion proteins can be synthesised and purified. Beta-galactosidase segment can be cleaved off with cyanogen bromide and purify the A and B chains. They can be joined by disulphide bridge formation (which isn’t efficient).

32
Q

What is an alternative method for joining the chains of A and B insulin?

A

Synthesis of proinsulin alone can help to form the disulphide bonds, followed by the cleavage of the C chain.

33
Q

What is an alternative to using inactivated infectious agents for vaccines?

A

Using viral proteins, such as part of the protein coat of a virus.

34
Q

What is the benefit of this method for producing vaccines?

A

They are 100% safe - the inactivated infectious agent could be harmful if not completely inactivated.

35
Q

What is a live recombinant virus vaccine?

A

When the virus coat protein is ligated into a vaccinia virus genome under control of the vaccinia promoter. The vaccinia causes disease in cows but is harmless to humans and provides immunity to smallpox.

36
Q

What other diseases can live recombinant virus vaccines be used for?

A

Hepatitis b.

37
Q

How else can vaccines be produced?

A

Pharming in plants.

38
Q

What are the benefits of producing vaccines in pharmed plants over animals?

A

It is easier to grow and harvest plants, reduced technology required, cheaper and may be suitable for developing countries.

39
Q

What are examples of vaccines from pharmed plants?

A

Hepatitis B HbaAg, measles virus and respiratory syncytial virus.

40
Q

What is the problem with plant pharming for vaccines?

A

The yield is too low to generate complete immunity

41
Q

How could the low yield of vaccine in plant pharming be fixed?

A

Expressing the genes in chloroplasts, despite post-translational processing being different than in the cytoplasm.